Cancer Research and Treatment (2024)

Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000-2009: Multicenter Study
Mee-Yon Cho, Joon Mee Kim, Jin Hee Sohn, Mi-Jung Kim, Kyoung-Mee Kim, Woo Ho Kim, Hyunki Kim, Myeong-Cherl Kook, Do Youn Park, Jae Hyuk Lee, HeeKyung Chang, Eun Sun Jung, Hee Kyung Kim, So-Young Jin, Joon Hyuk Choi, Mi Jin Gu, Sujin Kim, Mi Seon Kang, Chang Ho Cho, Moon-Il Park, Yun Kyung Kang, Youn Wha Kim, Sun Och Yoon, Han Ik Bae, Mee Joo, Woo Sung Moon, Dae Young Kang, Sei Jin Chang
Cancer Res Treat. 2012;44(3):157-165. Published online September 30, 2012
DOI: https://doi.org/10.4143/crt.2012.44.3.157
AbstractCancer Research and Treatment (2)PDFPubReaderePub
PURPOSE
As a result of various independently proposed nomenclatures and classifications, there is confusion in the diagnosis and prediction of biological behavior of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). A comprehensive nationwide study is needed in order to understand the biological characteristics of GEP-NETs in Korea.
MATERIALS AND METHODS
We collected 4,951 pathology reports from 29 hospitals in Korea between 2000 and 2009.Kaplan-Meier survival analysis was used to determine the prognostic significance of clinicopathological parameters.
RESULTS
Although the GEP-NET is a relatively rare tumor in Korea, its incidence has increased during the last decade, with the most significant increase found in the rectum. The 10-year survival rate for well-differentiated endocrine tumor was 92.89%, in contrast to 85.74% in well differentiated neuroendocrine carcinoma and 34.59% in poorly differentiated neuroendocrine carcinoma. Disease related death was most common in the biliary tract (62.2%) and very rare in the rectum (5.2%). In Kaplan-Meier survival analysis, tumor location, histological classification, extent, size, mitosis, Ki-67 labeling index, synaptophysin expression, lymphovascular invasion, perineural invasion, and lymph node metastasis showed prognostic significance (p<0.05), however, chromogranin expression did not (p=0.148). The 2000 and 2010 World Health Organization (WHO) classification proposals were useful for prediction of the prognosis of GEP-NET.
CONCLUSION
The incidence of GEP-NET in Korea has shown a remarkable increase during the last decade, however, the distribution of tumors in the digestive system differs from that of western reports. Assessment of pathological parameters, including immunostaining, is crucial in understanding biological behavior of the tumor as well as predicting prognosis of patients with GEP-NET.

Citations

Citations to this article as recorded byCancer Research and Treatment (5)

  • Risk Factor Analysis of Lymph Node Metastasis for Rectal Neuroendocrine Tumors: Who Needs a Radical Resection in Rectal Neuroendocrine Tumors Sized 1–2 cm?
    Jin Sun Choi, Min Jung Kim, Rumi Shin, Ji Won Park, Seung Chul Heo, Seung-Yong Jeong, Kyu Joo Park, Seung-Bum Ryoo
    Annals of Surgical Oncology.2024;[Epub]CrossRef
  • Somatostatin receptor 2 (SSTR2) expression is associated with better clinical outcome and prognosis in rectal neuroendocrine tumors
    Joo Young Kim, Jisup Kim, Yong-il Kim, Dong-Hoon Yang, Changhoon Yoo, In Ja Park, Baek-Yeol Ryoo, Jin-Sook Ryu, Seung-Mo Hong
    Scientific Reports.2024;[Epub]CrossRef
  • Endoscopic mucosal resection using anchored snare Tip-in versus precut technique for small rectal neuroendocrine tumors
    Seung Wook Hong, Dong-Hoon Yang, Yoo Jin Lee, Dong Hoon Baek, Jaeyoung Chun, Hyun Gun Kim, Sung Joo Kim, Seung-Mo Hong, Dae-Seong Myung
    The Korean Journal of Internal Medicine.2024; 39(2): 238.CrossRef
  • Assessing risk stratification in long-term outcomes of rectal neuroendocrine tumors following endoscopic resection: a multicenter retrospective study
    Hyun Jin Lee, Yun Seo, Chang Kyo Oh, Ji Min Lee, Hyun Ho Choi, Tae-Geun Gweon, Sung-Hak Lee, Dae Young Cheung, Jin Il Kim, Soo-Heon Park, Han Hee Lee
    Scandinavian Journal of Gastroenterology.2024; 59(7): 868.CrossRef
  • Clinicopathological Characteristics, Survival and Prognostic Factors in Gastrointestinal Large Cell Neuroendocrine Carcinoma
    Lele Chang, Xuemei Zhang, Jiaxin Li, Qingwei Li
    American Journal of Clinical Oncology.2024; 47(8): 363.CrossRef
  • Comparison of endoscopic resection therapies for rectal neuroendocrine tumors
    Meijiao Lu, Hongxia Cui, Mingjie Qian, Yating Shen, Jianhong Zhu
    Minimally Invasive Therapy & Allied Technologies.2024; 33(4): 207.CrossRef
  • Klinische Bedeutung von neuroendokrinen Tumoren
    Philipp E. Hartrampf, Sebastian E. Serfling, Takahiro Higuchi, Jörg Bojunga, Alexander Weich, Rudolf A. Werner
    Die Radiologie.2024; 64(7): 536.CrossRef
  • Mixed neuroendocrine–non-neuroendocrine neoplasm of the bile duct with long-term prognosis after neoadjuvant chemotherapy
    Shinya Nakamura, Masahiro Serikawa, Yasutaka Ishii, Yumiko Tatsukawa, Juri Ikemoto, Sayaka Miyamoto, Kenichiro Uemura, Shinya Takahashi, Koji Arihiro, Shiro Oka
    Clinical Journal of Gastroenterology.2024; 17(4): 717.CrossRef
  • Advancements in Neuroendocrine Neoplasms: Imaging and Future Frontiers
    Luigi Asmundo, Francesco Rizzetto, Michael Blake, Mark Anderson, Amirkasra Mojtahed, William Bradley, Anuradha Shenoy-Bhangle, Carlos Fernandez-del Castillo, Motaz Qadan, Cristina Ferrone, Jeffrey Clark, Valentina Ambrosini, Maria Picchio, Paola Mapelli,
    Journal of Clinical Medicine.2024; 13(11): 3281.CrossRef
  • Primary coexisting adenocarcinoma of the colon and neuroendocrine tumor of the duodenum: A case report and review of the literature
    Song Fei, Wei-Dong Wu, Han-Shuo Zhang, Shao-Jie Liu, Dan Li, Bo Jin
    World Journal of Gastrointestinal Surgery.2024; 16(8): 2724.CrossRef
  • Pancreatic neuroendocrine tumors: tailoring imaging to specific clinical scenarios
    Katerina S. Konstantinoff, Ajaykumar C. Morani, Thomas A. Hope, Priya R. Bhosale, Isaac R. Francis, Motoyo Yano, Amir Iravani, Nikolaos A. Trikalinos, Malak Itani
    Abdominal Radiology.2023; 48(5): 1843.CrossRef
  • Is lymphatic invasion of microrectal neuroendocrine tumors an incidental event?: A case report
    Jing-Xue Ran, Liang-Bi Xu, Wan-Wei Chen, Hao-Yi Yang, Yan Weng, Yong-Mei Peng
    World Journal of Clinical Cases.2023; 11(4): 859.CrossRef
  • Comparison of Metastatic Patterns Among Neuroendocrine Tumors, Neuroendocrine Carcinomas, and Nonneuroendocrine Carcinomas of Various Primary Organs
    Hyung Kyu Park, Ghee Young Kwon
    Journal of Korean Medical Science.2023;[Epub]CrossRef
  • Somatostatin receptor 2 in 10 different types of human non-neoplastic gastrointestinal neuroendocrine cells
    Hirofumi Watanabe, Fumiyoshi Fujishima, Michiaki Unno, Hironobu Sasano, Takashi Suzuki
    Pathology - Research and Practice.2023; 244: 154418.CrossRef
  • Different miRNAs Related to FBXW7 Mutations or High Mitotic Indices Contribute to Rectal Neuroendocrine Tumors: A Pilot Study
    Ho Suk Kang, Ha Young Park, Hyun Lim, Il Tae Son, Min-Jeong Kim, Nan Young Kim, Min Jeong Kim, Eun Sook Nam, Seong Jin Cho, Mi Jung Kwon
    International Journal of Molecular Sciences.2023; 24(7): 6329.CrossRef
  • High-Grade Pure Esophageal Neuroendocrine Carcinoma Arising From Barrett’s Mucosa: A Rare Phenomenon
    Parth Patel, Eli A Zaher, Hasan Sqour
    Cureus.2023;[Epub]CrossRef
  • Clinicopathologic Impact of Peptide Hormonal Expression in Rectal Neuroendocrine Tumors
    Jisup Kim, Dong-Hoon Yang, HaeSung Jung, HyungJun Cho, Hyeung-Jin Jang, Changhoon Yoo, In Ja Park, Baek-Yeol Ryoo, Jin-Sook Ryu, Seung-Mo Hong
    Archives of Pathology & Laboratory Medicine.2023; 147(7): 797.CrossRef
  • Understanding the increasing incidence of neuroendocrine tumors
    Surabhi Pathak, Jason S. Starr, Thorvardur Halfdanarson, Mohamad Bassam Sonbol
    Expert Review of Endocrinology & Metabolism.2023; 18(5): 377.CrossRef
  • Pancreatic Neuroendocrine Tumor (Pan-NET) Presented by Abdominal Pain: A Case Report and Literature Review
    Matteo Regolo, Nicolas Cardaci, Clara Salmeri, Alfredo Laudani, Michele Colaci, Massimo Ippolito, Fabio Motta, Salvatore Magrì, Stefanie Parisi, Alfredo Gaetano Torcitto, Lorenzo Malatino
    Journal of Clinical Medicine.2023; 12(20): 6617.CrossRef
  • Clinical Value of Clip-and-Snare Assisted Endoscopic Submucosal Resection in Treatment of Rectal Neuroendocrine Tumors
    Xin-Tong Jiang, Yang Hu, Jian Gong, Shi-Bin Guo
    Visceral Medicine.2023; 39(5): 140.CrossRef
  • Clinicopathological characteristics of extrahepatic biliary neuroendocrine neoplasms in the gallbladder, extrahepatic biliary tract, and ampulla of Vater: A single-center cross-sectional study
    Young Mok Park, Hyung Il Seo, Byeong Gwan Noh, Suk Kim, Seung Baek Hong, Nam Kyung Lee, Dong Uk Kim, Sung Yong Han
    Annals of Hepato-Biliary-Pancreatic Surgery.2023; 27(4): 380.CrossRef
  • Rectal Neuroendocrine Neoplasms: Why Is There a Global Variation?
    Jack Cope, Raj Srirajaskanthan
    Current Oncology Reports.2022; 24(3): 257.CrossRef
  • Clinicopathologic Characteristics of Gastroenteropancreatic Neuroendocrine Tumors: Experience of a National Referral Hospital in Indonesia
    Marini Stephanie, Nur Rahadiani, Hasan Maulahela, Ridho Ardhi Syaiful, Diah Rini Handjari, Ening Krisnuhoni
    Open Access Macedonian Journal of Medical Sciences.2022; 10(A): 101.CrossRef
  • Update on Epidemiology, Diagnosis, and Biomarkers in Gastroenteropancreatic Neuroendocrine Neoplasms
    Daisuke Takayanagi, Hourin Cho, Erika Machida, Atsushi Kawamura, Atsuo Takashima, Satoshi Wada, Takuya Tsunoda, Takashi Kohno, Kouya Shiraishi
    Cancers.2022; 14(5): 1119.CrossRef
  • Neuroendocrine Tumors: a Relevant Clinical Update
    Emma N. Rizen, Alexandria T. Phan
    Current Oncology Reports.2022; 24(6): 703.CrossRef
  • A small, low-grade rectal neuroendocrine tumor with lateral pelvic lymph node metastasis: a case report
    Seonhui Shin, Young-In Maeng, Seyun Jung, Chun-Seok Yang
    Annals of Coloproctology.2022; 38(4): 327.CrossRef
  • Rectal neuroendocrine neoplasms: what the radiologists should know
    Mayur Virarkar, Dheeraj R. Gopireddy, Ajaykumar C. Morani, Ahmad Alkhasawneh, Sergio Piotr Klimkowski, Sindhu Kumar, Chandana Lall, Priya Bhosale
    Abdominal Radiology.2022; 47(12): 4016.CrossRef
  • Risk Factors for Lymph Node Metastasis and Oncologic Outcomes in Small Rectal Neuroendocrine Tumors with Lymphovascular Invasion
    Seung-Joo Nam, Byung Chang Kim, Hee Jin Chang, Han Ho Jeon, Junho Kim, Su Young Kim
    Gut and Liver.2022; 16(2): 228.CrossRef
  • Clinical related factors to neuroendocrine tumors in Ecuadorian patients: a logistic biplot approach
    Karime Montes Escobar, José Luis Vicente Villardón, Daniel Fabricio Alarcón Cano, Aline Siteneski
    Investigación Clínica.2022; 63(1): 19.CrossRef
  • Clinicopathological Characteristics of Gastroenteropancreatic Neuroendocrine Tumors
    Mustafa Şentürk, Berkan Acar, Mehmet Aykut Yildirim, Murat Çakir, Tevfik Küçükkartallar, Celalettin Vatansev
    Pancreas.2022; 51(2): 159.CrossRef
  • Epidemiology of neuroendocrine neoplasmas in Japan: based on analysis of hospital-based cancer registry data, 2009 – 2015
    Tomonobu Koizumi, Kengo Otsuki, Yuriko Tanaka, Shintaro Kanda
    BMC Endocrine Disorders.2022;[Epub]CrossRef
  • State of the Art in Endoscopic Therapy for the Management of Gastroenteropancreatic Neuroendocrine Tumors
    Apostolis Papaefthymiou, Faidon-Marios Laskaratos, Apostolos Koffas, Anastasios Manolakis, Paraskevas Gkolfakis, Sergio Coda, Mikael Sodergren, Noriko Suzuki, Christos Toumpanakis
    Current Treatment Options in Oncology.2022; 23(7): 1014.CrossRef
  • Clinical characteristics, prognostic factors, and survival trends in esophageal neuroendocrine carcinomas: Apopulation‐based study
    Chuyan Chen, Haiyi Hu, Zhibo Zheng, Yi Yang, Wei Chen, Xinwei Qiao, Peng Li, Shutian Zhang
    Cancer Medicine.2022; 11(24): 4935.CrossRef
  • Underwater endoscopic mucosal resection for rectal neuroendocrine tumors (with videos): a single center retrospective study
    Haitao Shi, Chuying Wang, Jie Wu, Bin Qin, Jiong Jiang, Na Liu, Yahua Song, Yun Qin, Shiyang Ma
    BMC Gastroenterology.2022;[Epub]CrossRef
  • Endoscopic treatment for rectal neuroendocrine tumor: which method is better?
    Seung Min Hong, Dong Hoon Baek
    Clinical Endoscopy.2022; 55(4): 496.CrossRef
  • Clinical outcomes of gastroduodenal neuroendocrine tumors according to their WHO grade: A single-institutional retrospective analysis
    Dae Gon Ryu, Su Jin Kim, Cheol Woong Choi, Dae Hwan Kang, Hyung Wook Kim, Su Bum Park, Hyeong Seok Nam, Si Hak Lee, Sun Hwi Hwang
    Medicine.2022; 101(37): e30397.CrossRef
  • Establishment and validation of a clinicopathological prognosis model of gastroenteropancreatic neuroendocrine carcinomas
    Jing Chen, Yibing Liu, Ke Xu, Fei Ren, Bowen Li, Hong Sun
    Frontiers in Oncology.2022;[Epub]CrossRef
  • Incidence and survival of neuroendocrine neoplasia in England 1995–2018: A retrospective, population-based study
    Benjamin E. White, Brian Rous, Kandiah Chandrakumaran, Kwok Wong, Catherine Bouvier, Mieke Van Hemelrijck, Gincy George, Beth Russell, Rajaventhan Srirajaskanthan, John K. Ramage
    The Lancet Regional Health - Europe.2022; 23: 100510.CrossRef
  • The risk and prognostic factors for G1 pancreatic neuroendocrine tumors: A retrospective analysis of the SEER database
    Zhengqi Wu, Xiaotong Qiu, Yao Zhi, Xiaoju Shi, Guoyue Lv
    Frontiers in Oncology.2022;[Epub]CrossRef
  • MODERN PATHOLOGICAL CONSTELLATION FOR GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS AND IMMUNOHISTOCHEMICAL PANEL
    P. Vladova
    Trakia Journal of Sciences.2022; 20(4): 346.CrossRef
  • An esophageal submucosal tumor treated with submucosal tunneling endoscopic resection: an unexpected result
    Ming-Yan Cai, Mariana Ferreira Cardoso, Yan Zhu, Yun-Shi Zhong, Ping-Hong Zhou
    Gastroenterology Report.2021; 9(3): 269.CrossRef
  • A systematic review of chromogranin A (CgA) and its biomedical applications, unveiling its structure-related functions
    Kyuhyung Choi, Manhyuk Han, Seung Joong Kim
    Journal of the Korean Physical Society.2021; 78(5): 427.CrossRef
  • Current Paradigm of Treatment for Pancreatic Neuroendocrine Tumor
    Min Je Sung, Moon Jae Chung
    The Korean Journal of Pancreas and Biliary Tract.2021; 26(1): 24.CrossRef
  • Epidemiology, Incidence, and Prevalence of Neuroendocrine Neoplasms: Are There Global Differences?
    Satya Das, Arvind Dasari
    Current Oncology Reports.2021;[Epub]CrossRef
  • Targeted Cancer Therapy: What’s New in the Field of Neuroendocrine Neoplasms?
    Anna La Salvia, Paula Espinosa-Olarte, Maria Del Carmen Riesco-Martinez, Beatriz Anton-Pascual, Rocío Garcia-Carbonero
    Cancers.2021; 13(7): 1701.CrossRef
  • Systemic Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors in Korea: Literature Review and Expert Opinion
    Changhoon Yoo, Chung Ryul Oh, Seung-Tae Kim, Woo Kyun Bae, Hye-Jin Choi, Do-Youn Oh, Myung-Ah Lee, Baek-Yeol Ryoo
    Cancer Research and Treatment.2021; 53(2): 291.CrossRef
  • Clinicopathological characteristics and prognosis of 232 patients with poorly differentiated gastric neuroendocrine neoplasms
    Deng Han, Yuan-Liang Li, Zhi-Wei Zhou, Fei Yin, Jie Chen, Fang Liu, Yan-Fen Shi, Wei Wang, Yu Zhang, Xian-Jun Yu, Jian-Ming Xu, Run-Xiang Yang, Chao Tian, Jie Luo, Huang-Ying Tan
    World Journal of Gastroenterology.2021; 27(21): 2895.CrossRef
  • Standardization of the pathologic diagnosis of appendiceal mucinous neoplasms
    Dong-Wook Kang, Baek-hui Kim, Joon Mee Kim, Jihun Kim, Hee Jin Chang, Mee Soo Chang, Jin-Hee Sohn, Mee-Yon Cho, So-Young Jin, Hee Kyung Chang, Hye Seung Han, Jung Yeon Kim, Hee Sung Kim, Do Youn Park, Ha Young Park, So Jeong Lee, Wonae Lee, Hye Seung Lee,
    Journal of Pathology and Translational Medicine.2021; 55(4): 247.CrossRef
  • Multi-institutional development and validation of a nomogram to predict recurrence after curative resection of gastric neuroendocrine/mixed adenoneuroendocrine carcinoma
    Hualong Zheng, YaJun Zhao, Qingliang He, Hankun Hao, Yantao Tian, Bingbing Zou, Lixin Jiang, Xiantu Qiu, Yanbing Zhou, Zhi Li, Yanchang Xu, Gang Zhao, Fangqin Xue, Shuliang Li, Weihua Fu, Yongxiang Li, Xiaojun Zhou, Yong Li, Zhenggang Zhu, Jinping Chen, Z
    Gastric Cancer.2021; 24(2): 503.CrossRef
  • Comparative study of laparoscopic versus open radical gastrectomy in advanced gastric neuroendocrine carcinoma: Analysis from a high-volume institution
    Ya-Jun Zhao, Lv-Ping Zhuang, Yi-Yang Liu, Ren-Cheng Chen, Jun Zhang, Hai-Xing Zhu, Yong-Cang Wang, Hao You, Ming-Wei Zhang, Xin-Yang He
    Asian Journal of Surgery.2020; 43(3): 488.CrossRef
  • Potential Pitfalls in Diagnostic Digital Image Analysis: Experience with Ki-67 and PHH3 in Gastrointestinal Neuroendocrine Tumors
    Sean M Hacking, Sujata Sajjan, Lili Lee, Yonah Ziemba, Mallorie Angert, Yihe Yang, Cao Jin, Hector Chavarria, Nidhi Kataria, Swachi Jain, Mansoor Nasim
    Pathology - Research and Practice.2020; 216(3): 152753.CrossRef
  • Imaging and Contrast-enhanced Ultrasound features of duodenal neuroendocrine tumor: A case report
    Yan-Qun Zhang, Jie-Xian Wen, Rong-Kui Luo, Hai-Xia Yuan, Wen-Ping Wang
    Clinical Hemorheology and Microcirculation.2020; 76(1): 27.CrossRef
  • Rare cancers are not rare in Asia as well: The rare cancer burden in East Asia
    Tomohiro Matsuda, Young-Joo Won, RuRu Chun-ju Chiang, Jiwon Lim, Kumiko Saika, Keisuke Fukui, Wen-Chung Lee, Laura Botta, Alice Bernasconi, Annalisa Trama
    Cancer Epidemiology.2020; 67: 101702.CrossRef
  • Islet Tumors
    Tiffany J. Sinclair, George A. Poultsides
    Advances in Surgery.2020; 54: 69.CrossRef
  • Primary Large Cell Neuroendocrine Carcinoma of the Esophagus Disguised as a Food Impaction
    Harsh D. Patel, Jared Beck, Archish Kataria, Glenn W. Gross, Juan Echavarria
    ACG Case Reports Journal.2020; 7(6): e00384.CrossRef
  • Pancreatic nodule positive for 68-Ga-DOTAPEPTIDE-PET: NET or ectopic spleen? The importance of a good differential diagnosis
    Francesco Serra, Gianluca De Matteis, Sara Delfanti, Monica Feltri, Alessandro Vanoli, Giorgio Cavenaghi, Anna Gallotti, Marcello Maestri, Silvia Brugnatelli
    Clinical and Translational Imaging.2020; 8(5): 307.CrossRef
  • Gastric neuroendocrine tumor with Helicobacter pylori-associated chronic gastritis
    Giovanni Serio, Armando Dell’Anna, Anna Debenedittis, Elisa Stasi, Maria Arcangela Cascarano
    International Journal of Surgery Case Reports.2020; 75: 361.CrossRef
  • Chromogranin A Expression in Rectal Neuroendocrine Tumors Is Associated With More Aggressive Clinical Behavior and a Poorer Prognosis
    Jisup Kim, Joo Young Kim, Eun Hye Oh, Changhoon Yoo, In Ja Park, Dong-Hoon Yang, Baek-Yeol Ryoo, Jin-Sook Ryu, Seung-Mo Hong
    American Journal of Surgical Pathology.2020; 44(11): 1496.CrossRef
  • Clinicopathological characteristics and prognosis of 77 cases with type 3 gastric neuroendocrine tumours
    Yuan-Liang Li, Xu-Dong Qiu, Jie Chen, Yu Zhang, Jie Li, Jian-Ming Xu, Chao Wang, Zhi-Rong Qi, Jie Luo, Huang-Ying Tan
    World Journal of Gastrointestinal Oncology.2020; 12(12): 1416.CrossRef
  • Clinicopathological Study of 100 Cases of Neuroendocrine Neoplasms of the Gastroenteropancreatic System: A Tertiary Cancer Center Experience
    Satarupa Tarak Nath Samanta, Shailee Paresh Bhai Mehta, Trupti S Patel, Dhaval H Jetly
    Indian Journal of Medical and Paediatric Oncology.2020; 41(03): 340.CrossRef
  • Validation and proposed modification of the 8th edition American Joint Committee on Cancer staging system for patients with esophageal neuroendocrine neoplasms: Evaluation of a revised lymph node classification
    Haihong Wang, Yaobing Chen, Guoliang Pi, Ying Zhu, Shengli Yang, Hong Mei, Zhenyu Lin, Tao Zhang
    Oncology Letters.2020;[Epub]CrossRef
  • Efficacy and safety of lanreotide in Korean patients with metastatic, well-differentiated gastroenteropancreatic-neuroendocrine tumors: a retrospective analysis
    Junho Kang, Changhoon Yoo, Hee-Sang Hwang, Seung-Mo Hong, Kyu-pyo Kim, Sun Young Kim, Yong-Sang Hong, Tae Won Kim, Baek-Yeol Ryoo
    Investigational New Drugs.2019; 37(4): 763.CrossRef
  • A rare rarity: Neuroendocrine tumor of the esophagus
    Elisa Giannetta, Valentina Guarnotta, Francesca Rota, Federica de Cicco, Federica Grillo, Annamaria Colao, Antongiulio Faggiano
    Critical Reviews in Oncology/Hematology.2019; 137: 92.CrossRef
  • Preoperative diagnosis of well‐differentiated neuroendocrine tumor in common hepatic duct by brush cytology: A case report
    Jiwoon Choi, Kyong Joo Lee, Sung Hoon Kim, Mee‐Yon Cho
    Diagnostic Cytopathology.2019; 47(7): 720.CrossRef
  • Recent Updates in the Management of Advanced Pancreatic Neuroendocrine Tumors
    Chang Min Cho
    The Korean Journal of Gastroenterology.2019; 73(3): 124.CrossRef
  • Clinical significance of programmed death 1/programmed death ligand 1 pathway in gastric neuroendocrine carcinomas
    Min-Wei Yang, Xue-Liang Fu, Yong-Sheng Jiang, Xiao-Jing Chen, Ling-Ye Tao, Jian-Yu Yang, Yan-Miao Huo, Wei Liu, Jun-Feng Zhang, Pei-Feng Liu, Qiang Liu, Rong Hua, Zhi-Gang Zhang, Yong-Wei Sun, De-Jun Liu
    World Journal of Gastroenterology.2019; 25(14): 1684.CrossRef
  • Endoscopic Ultrasound-Guided Radiofrequency Ablation: A New Therapeutic Approach for Pancreatic Neuroendocrine Tumors
    Kira Oleinikov, Alain Dancour, Julia Epshtein, Ariel Benson, Haggi Mazeh, Ilanit Tal, Shay Matalon, Carlos A Benbassat, Dan M Livovsky, Eran Goldin, David J Gross, Harold Jacob, Simona Grozinsky-Glasberg
    The Journal of Clinical Endocrinology & Metabolism.2019; 104(7): 2637.CrossRef
  • Clinical analysis of 547 patients with neuroendocrine tumors in a Chinese population: A single‐center study
    Lijie Song, Xuejia Zhai, Shunli Yu, Yihui Ma, Feng Wang, Xuxu Yu, Shuang Tao, Yujin Lian, Minjie Yang, Weili Tao, Qingxia Fan
    Cancer Medicine.2019; 8(8): 3729.CrossRef
  • Endoscopic, transanal, laparoscopic, and transabdominal management of rectal neuroendocrine tumors
    Louis de Mestier, Diane Lorenzo, Caroline Fine, Jérôme Cros, Olivia Hentic, Thomas Walter, Yves Panis, Anne Couvelard, Guillaume Cadiot, Philippe Ruszniewski
    Best Practice & Research Clinical Endocrinology & Metabolism.2019; 33(5): 101293.CrossRef
  • Intrapancreatic accessory spleen false positive to 68Ga-Dotatoc: case report and literature review
    Francesco Lancellotti, Luca Sacco, Saverio Cerasari, Vittoria Bellato, Simone Cicconi, Antonio Ciardi, Edoardo Maria Muttillo, Tiziana Feola, Roberto Caronna, Piero Chirletti
    World Journal of Surgical Oncology.2019;[Epub]CrossRef
  • Novel Finding of Paired Box 5 (PAX5) Cytoplasmic Staining in Well-differentiated Rectal Neuroendocrine Tumors (Carcinoids) and Its Diagnostic and Potentially Prognostic Utility
    Zhiyan Fu, Chunlai Zuo, Christine E. Sheehan, Deepa T. Patil, Jingmei Lin, Zhaohai Yang, Hwajeong Lee
    Applied Immunohistochemistry & Molecular Morphology.2019; 27(6): 454.CrossRef
  • Duodenal neuroendocrine tumors
    A. V. Alekberzade, N. N. Krylov, T. N. Garmanova, R. Shahbazov, F. Azari, K. S. Zuykova, E. D. Litovchenko
    Khirurgiya. Zhurnal im. N.I. Pirogova.2019; (7): 87.CrossRef
  • [68Ga]-Dota Peptide PET/CT in Neuroendocrine Tumors: Main Clinical Applications
    Elisabetta Giovannini, Giampiero Giovacchini, Elisa Borsò, Patrizia Lazzeri, Mattia Riondato, Rossella Leoncini, Valerio Duce, Andrea Ciarmiello
    Current Radiopharmaceuticals.2019; 12(1): 11.CrossRef
  • Multifocal G1-G2 gastric neuroendocrine tumors: Differentiating between Type I, II and III, a clinicopathologic review
    Khaled Algashaamy, Monica Garcia-Buitrago
    World Journal of Clinical Cases.2019; 7(17): 2413.CrossRef
  • Establishment and characterization of a novel neuroendocrine carcinoma cell line derived from a human ascending colon tumor
    Seiichi Shinji, Norihiko Sasaki, Takeshi Yamada, Michihiro Koizumi, Ryo Ohta, Akihisa Matsuda, Yasuyuki Yokoyama, Goro Takahashi, Masahiro Hotta, Keisuke Hara, Kohki Takeda, Koji Ueda, Sho Kuriyama, Toshiyuki Ishiwata, Yoshibumi Ueda, Takashi Murakami, Yo
    Cancer Science.2019; 110(12): 3708.CrossRef
  • Gastric neuroendocrine tumors
    A. V. Alekberzade, N. N. Krylov, E. M. Lipnitskiy, R. O. Shakhbazov, F. Azari
    Khirurgiya. Zhurnal im. N.I. Pirogova.2019; (12): 111.CrossRef
  • Resectability of Rectal Neuroendocrine Tumors Using Endoscopic Mucosal Resection with a Ligation Band Device and Endoscopic Submucosal Dissection
    Hong Kyu Lim, Seong Jun Lee, Dong Hoon Baek, Do Youn Park, Bong Eun Lee, Eun Young Park, Joon Woo Park, Gwang Ha Kim, Geun Am Song
    Gastroenterology Research and Practice.2019; 2019: 1.CrossRef
  • Epidemiological trends of neuroendocrine tumours over three decades in Queensland, Australia
    David Wyld, Mark H. Wan, Julie Moore, Nathan Dunn, Philippa Youl
    Cancer Epidemiology.2019; 63: 101598.CrossRef
  • Lymphovascular invasion as a prognostic value in small rectal neuroendocrine tumor treated by local excision: A systematic review and meta-analysis
    Ho Suk Kang, Mi Jung Kwon, Tae-Hwan Kim, Junhee Han, Young-Su Ju
    Pathology - Research and Practice.2019; 215(11): 152642.CrossRef
  • Gastroenteropancreatic Neuroendocrine Tumor with Hepatic Metastasis Misdiagnosed as Hepatocellular Carcinoma
    Seul Ki Kim, Sang Chul Kim, Seok Gyo Seo, Hong Joo Kim, Yong Kyun Cho, Woo Kyu Jeon, Byung Ik Kim
    The Korean Journal of Medicine.2019; 94(5): 449.CrossRef
  • Clinicopathologic Characteristics and Survival of Patients with Gastroenteropancreatic Neuroendocrine Neoplasm in a Multi-Ethnic Asian Institution
    WaiMeng Tai, SzeHuey Tan, DamienMengYew Tan, KelvinSiuHoong Loke, DavidCheeEng Ng, SeanXuexian Yan, JacquelineSiokGek Hwang, KiatHon Lim, LihMing Loh, PengChin Kek, BrianKimPoh Goh, SerYee Lee, AlexanderYawFui Chung, SimonYewKuang Ong
    Neuroendocrinology.2019; 108(4): 265.CrossRef
  • Primary Esophagogastric Neuroendocrine Carcinoma: a Retrospective Study from the Nottingham Upper Gastrointestinal Cancer Center
    Constantinos Savva, Philip Kaye, Irshad Soomro, Simon L. Parsons, Eleanor James, Srinivasan Madhusudan
    Journal of Gastrointestinal Cancer.2018; 49(1): 85.CrossRef
  • Transanal Endoscopic Microsurgery for Patients with Rare Rectal Tumors
    Xin Wu, Guole Lin, Huizhong Qiu, Jiaolin Zhou
    Journal of Laparoendoscopic & Advanced Surgical Techniques.2018; 28(5): 546.CrossRef
  • A case of small intestinal neuroendocrine carcinoma diagnosed using double-balloon endoscopy with long-term survival
    Seiji Kawano, Yuichi Miyashima, Yoshio Miyabe, Yoshinari Kawai, Toshihiro Murata, Masashi Uda, Toshihiro Inokuchi, Hiroyuki Okada
    Clinical Journal of Gastroenterology.2018; 11(3): 240.CrossRef
  • How should incidental NEN of the pancreas and gastrointestinal tract be followed?
    Riccardo Ariotti, Stefano Partelli, Francesca Muffatti, Valentina Andreasi, Francesca Della Sala, Massimo Falconi
    Reviews in Endocrine and Metabolic Disorders.2018; 19(2): 139.CrossRef
  • Identification of Phosphohistone H3 Cutoff Values Corresponding to Original WHO Grades but Distinguishable in Well-Differentiated Gastrointestinal Neuroendocrine Tumors
    Min Jeong Kim, Mi Jung Kwon, Ho Suk Kang, Kyung Chan Choi, Eun Sook Nam, Seong Jin Cho, Hye-Rim Park, Soo Kee Min, Jinwon Seo, Ji-Young Choe, Hyoung-Chul Park
    BioMed Research International.2018; 2018: 1.CrossRef
  • A meta-analysis of Prognostic factor of Pancreatic neuroendocrine neoplasms
    Yong Gao, Hao Gao, Guangfu Wang, Lingdi Yin, Wenbin Xu, Yunpeng Peng, Junli Wu, Kuirong Jiang, Yi Miao
    Scientific Reports.2018;[Epub]CrossRef
  • Everolimus in the treatment of neuroendocrine tumors: efficacy, side-effects, resistance, and factors affecting its place in the treatment sequence
    Lingaku Lee, Tetsuhide Ito, Robert T. Jensen
    Expert Opinion on Pharmacotherapy.2018; 19(8): 909.CrossRef
  • Pancreatic Neuroendocrine Neoplasms: A Role of Laparoscopy in Surgical Treatment: Review
    Jacek Szeliga, Marek Jackowski
    Surgical Laparoscopy, Endoscopy & Percutaneous Techniques.2018; 28(3): 147.CrossRef
  • Clinicopathological features and outcome for neuroendocrine neoplasms of gastroesophageal junction: A population‐based study
    Panpan Zhang, Wei Wang, Ming Lu, Changqing Zeng, Jie Chen, Enxiao Li, Huangying Tan, Wei Wang, Xianjun Yu, Qiyun Tang, Jiemin Zhao, Lin Shen, Jie Li
    Cancer Medicine.2018; 7(9): 4361.CrossRef
  • Neuroendocrine tumors with hepatic metastases: A review of evolving treatment options
    Steven D. Colquhoun
    Liver Research.2018; 2(2): 92.CrossRef
  • Endoscopic Treatment Outcome of Rectal Neuroendocrine Tumors Removed by Ligation-assisted Endoscopic Submucosal Resection
    Min Geun Gu, Si Hyung Lee
    The Korean Journal of Gastroenterology.2018; 72(3): 128.CrossRef
  • Clinicopathological features and prognosis of patients with gastric neuroendocrine tumors: A population‐based study
    Fang‐Xi Tian, Yu‐Qing Cai, Lv‐Ping Zhuang, Ming‐Fang Chen, Zhong‐Biao Xiu, Yi Zhang, Hong Liu, Zhi‐Hong Liu, Guo‐Ping Liu, Chen Zeng, Fei‐Ling Lin, Jing Liu, Si‐Ting Huang, Liang‐Zhi Zhang, Hua‐Yang Lin
    Cancer Medicine.2018; 7(11): 5359.CrossRef
  • Global burden of neuroendocrine tumors and changing incidence in Kentucky
    Aman Chauhan, Qian Yu, Neha Ray, Zainab Farooqui, Bin Huang, Eric B. Durbin, Thomas Tucker, Mark Evers, Susanne Arnold, Lowell B. Anthony
    Oncotarget.2018; 9(27): 19245.CrossRef
  • Gastroenteropancreatic neuroendocrine tumor registry study in China
    Lin Cong, Wenming Wu, Wenhui Lou, Jinwan Wang, Feng Gu, Jiaming Qian, Jianming Xu, Feng Bi, Sanjun Cai, Chengwei Tang, Yulong He, Jie Zhong, Yupei Zhao
    Journal of Pancreatology.2018; 1(1): 35.CrossRef
  • Incidence and clinical characteristics of gastroenteropancreatic neuroendocrine tumor in Korea:a single-center experience
    Chul-Hyun Lim, In Seok Lee, Byoung Yeon Jun, Jin Su Kim, Yu Kyung Cho, Jae Myung Park, Sang Young Roh, Myung Ah Lee, Sang Woo Kim, Myung-Gyu Choi
    The Korean Journal of Internal Medicine.2017; 32(3): 452.CrossRef
  • Uncommon Anal Neoplasms
    Amitesh C. Roy, David Wattchow, David Astill, Simron Singh, Susan Pendlebury, Kirsten Gormly, Eva Segelov
    Surgical Oncology Clinics of North America.2017; 26(1): 143.CrossRef
  • Surveillance and comparison of surgical prognosis for asymptomatic and symptomatic non-functioning pancreatic neuroendocrine tumors
    Wenhao Ge, Dongkai Zhou, Shaoyan Xu, Weilin Wang, Shusen Zheng
    International Journal of Surgery.2017; 39: 127.CrossRef
  • Recent updates on grading and classification of neuroendocrine tumors
    Joo Young Kim, Seung-Mo Hong, Jae Y. Ro
    Annals of Diagnostic Pathology.2017; 29: 11.CrossRef
  • Mixed adenoneuroendocrine carcinoma derived from the cystic duct: A case report
    Yu-ki Takemoto, Tomoyuki Abe, Hironobu Amano, Keiji Hanada, Akihito Okazaki, Tomoyuki Minami, Tsuyoshi Kobayashi, Masahiro Nakahara, Shuji Yonehara, Hideki Ohdan, Toshio Noriyuki
    International Journal of Surgery Case Reports.2017; 39: 29.CrossRef
  • Loss of Progesterone Receptor Expression Is an Early Tumorigenesis Event Associated with Tumor Progression and Shorter Survival in Pancreatic Neuroendocrine Tumor Patients
    Sung Joo Kim, Soyeon An, Jae Hoon Lee, Joo Young Kim, Ki-Byung Song, Dae Wook Hwang, Song Cheol Kim, Eunsil Yu, Seung-Mo Hong
    Journal of Pathology and Translational Medicine.2017; 51(4): 388.CrossRef
  • Clinical outcomes of everolimus in patients with advanced, nonfunctioning pancreatic neuroendocrine tumors: a multicenter study in Korea
    Kyong Joo Lee, Jae Hee Cho, Sang Hyub Lee, Si Young Song, Kwang Hyuk Lee, Seok Jeong, Ji Kon Ryu, Sang Myung Woo, Seungmin Bang, Jong Kyun Lee, Tae Hoon Lee, Woo Hyun Paik, Yong Tae Kim, Woo Jin Lee
    Cancer Chemotherapy and Pharmacology.2017; 80(4): 799.CrossRef
  • Clinicopathological, treatment, and prognosis study of 43 gastric neuroendocrine carcinomas
    De-Jun Liu, Xue-Liang Fu, Wei Liu, Lu-Ying Zheng, Jun-Feng Zhang, Yan-Miao Huo, Jiao Li, Rong Hua, Qiang Liu, Yong-Wei Sun
    World Journal of Gastroenterology.2017; 23(3): 516.CrossRef
  • Is endoscopic ultrasonography essential for endoscopic resection of small rectal neuroendocrine tumors?
    Su Bum Park, Dong Jun Kim, Hyung Wook Kim, Cheol Woong Choi, Dae Hwan Kang, Su Jin Kim, Hyeong Seok Nam
    World Journal of Gastroenterology.2017; 23(11): 2037.CrossRef
  • Predictive Factors for Lymph Node Metastasis and Prognostic Factors for Survival in Rectal Neuroendocrine Tumors
    Beonghoon Sohn, Yoomin Kwon, Seung-Bum Ryoo, Inho Song, Yoon-Hye Kwon, Dong Woon Lee, Sang Hui Moon, Ji Won Park, Seung-Yong Jeong, Kyu Joo Park
    Journal of Gastrointestinal Surgery.2017; 21(12): 2066.CrossRef
  • Efficacy of Precut Endoscopic Mucosal Resection for Treatment of Rectal Neuroendocrine Tumors
    Hoonsub So, Su Hyun Yoo, Seungbong Han, Gwang-un Kim, Myeongsook Seo, Sung Wook Hwang, Dong-Hoon Yang, Jeong-Sik Byeon
    Clinical Endoscopy.2017; 50(6): 585.CrossRef
  • Gastroenteropancreatic—origin neuroendocrine carcinomas
    Yong Gyun Won, Kyung-Jin Seo, Jiyeon Hyeon, Ok Ran Shin, Eundeok Chang, Der Sheng Sun, Hae Sung Won, Yoon Ho Ko, Sae Jung Na, Su Lim Lee, Young Mi Ku, Dong Soo Lee
    Medicine.2017; 96(49): e9009.CrossRef
  • Sex comb on midleg like-2 is a novel specific marker for the diagnosis of gastroenteropancreatic neuroendocrine tumors
    Jiao-Jiao Yang, Hua Huang, Ming-Bing Xiao, Feng Jiang, Wen-Kai Ni, Yi-Fei Ji, Cui-Hua Lu, Run-Zhou Ni
    Experimental and Therapeutic Medicine.2017; 14(2): 1749.CrossRef
  • A nation-wide retrospective epidemiological study of gastroenteropancreatic neuroendocrine neoplasms in china
    Jin-Hu Fan, Yu-Qing Zhang, Su-Sheng Shi, Yuan-Jia Chen, Xing-Hua Yuan, Li-Ming Jiang, Shao-Ming Wang, Li Ma, Yu-Tong He, Chang-Yan Feng, Xi-Bin Sun, Qing Liu, Katrina Deloso, Yihebali Chi, You-Lin Qiao
    Oncotarget.2017; 8(42): 71699.CrossRef
  • Irinotecan plus cisplatin followed by octreotide long-acting release maintenance treatment in advanced gastroenteropancreatic neuroendocrine carcinoma: IPO-NEC study
    Jie Li, Ming Lu, Zhihao Lu, Zhongwu Li, Yiqiang Liu, Li Yang, Jian Li, Xiaotian Zhang, Jun Zhou, Xicheng Wang, Jifang Gong, Jing Gao, Yan Li, Lin Shen
    Oncotarget.2017; 8(15): 25669.CrossRef
  • Cap-assisted EMR for rectal neuroendocrine tumors: comparisons with conventional EMR and endoscopic submucosal dissection (with videos)
    Dong-Hoon Yang, Yangsoon Park, Sang Hyoung Park, Kyung-Jo Kim, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang
    Gastrointestinal Endoscopy.2016; 83(5): 1015.CrossRef
  • Surgical Treatment as a Principle for Patients with High-Grade Pancreatic Neuroendocrine Carcinoma: A Nordic Multicenter Comparative Study
    Sven-Petter Haugvik, Eva Tiensuu Janson, Pia Österlund, Seppo W. Langer, Ragnhild Sørum Falk, Knut Jørgen Labori, Lene Weber Vestermark, Henning Grønbæk, Ivar Prydz Gladhaug, Halfdan Sorbye
    Annals of Surgical Oncology.2016; 23(5): 1721.CrossRef
  • Evaluation of the risk factors associated with rectal neuroendocrine tumors: a big data analytic study from a health screening center
    Jeung Hui Pyo, Sung Noh Hong, Byung-Hoon Min, Jun Haeng Lee, Dong Kyung Chang, Poong-Lyul Rhee, Jae Jun Kim, Sun Kyu Choi, Sin-Ho Jung, Hee Jung Son, Young-Ho Kim
    Journal of Gastroenterology.2016; 51(12): 1112.CrossRef
  • Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts
    Joo Young Kim, Seung-Mo Hong
    Archives of Pathology & Laboratory Medicine.2016; 140(5): 437.CrossRef
  • Metronomic temozolomide as second line treatment for metastatic poorly differentiated pancreatic neuroendocrine carcinoma
    C. De Divitiis, C. von Arx, A. M. Grimaldi, D. Cicala, F. Tatangelo, A. Arcella, G. M. Romano, E. Simeone, R. V. Iaffaioli, P. A. Ascierto, S. Tafuto
    Journal of Translational Medicine.2016;[Epub]CrossRef
  • Epidemiological features of gastroenteropancreatic neuroendocrine tumors in Chengdu city with a population of 14 million based on data from a single institution
    Lin-Jie Guo, Chun-Hui Wang, Cheng-Wei Tang
    Asia-Pacific Journal of Clinical Oncology.2016; 12(3): 284.CrossRef
  • The Clinicopathologic Features and Treatment of 607 Hindgut Neuroendocrine Tumor (NET) Patients at a Single Institution
    Seung Tae Kim, Sang Yun Ha, Jeeyun Lee, Sung No Hong, Dong Kyung Chang, Young Ho Kim, Yoon Ah Park, Jung Wook Huh, Yong Beom Cho, Seong Hyeon Yun, Woo Yong Lee, Hee Cheol Kim, Young Suk Park
    Medicine.2016; 95(19): e3534.CrossRef
  • Clinicopathological Profile of Pure Neuroendocrine Neoplasms of the Esophagus: A South Indian Center Experience
    Govind Babu Kanakasetty, Loknatha Dasappa, Kuntegowdanahalli Chinnagiriyappa Lakshmaiah, Mangesh Kamath, Linu Abraham Jacob, Suresh Babu Mallekavu, Lakkavalli Krishnappa Rajeev, Rudresha Antapura Haleshappa, Lokesh Kadabur Nagendrappa, Smitha Carol Saldan
    Journal of Oncology.2016; 2016: 1.CrossRef
  • Endoscopic treatments for rectal neuroendocrine tumors smaller than 16 mm: a meta-analysis
    Hai-Ping Zhang, Wei Wu, Sheng Yang, Jun Lin
    Scandinavian Journal of Gastroenterology.2016; 51(11): 1345.CrossRef
  • Lymph node size is not a reliable criterion for predicting nodal metastasis in rectal neuroendocrine tumours
    B. C. Kim, Y. E. Kim, H. J. Chang, S. H. Lee, E. G. Youk, D.‐S. Lee, J. B. Lee, E.‐J. Lee, M. J. Kim, D. K. Sohn, J. H. Oh
    Colorectal Disease.2016;[Epub]CrossRef
  • Prognostic Validity of the American Joint Committee on Cancer and the European Neuroendocrine Tumors Staging Classifications for Pancreatic Neuroendocrine Tumors
    Jae Hee Cho, Ji Kon Ryu, Si Young Song, Jin-Hyeok Hwang, Dong Ki Lee, Sang Myung Woo, Young-Eun Joo, Seok Jeong, Seung-Ok Lee, Byung Kyu Park, Young Koog Cheon, Jimin Han, Tae Nyeun Kim, Jun Kyu Lee, Sung-Hoon Moon, Hyunjin Kim, Eun Taek Park, Jae Chul Hw
    Pancreas.2016; 45(7): 941.CrossRef
  • Endoscopic Resection for Small Rectal Neuroendocrine Tumors: Comparison of Endoscopic Submucosal Resection with Band Ligation and Endoscopic Submucosal Dissection
    Byoung Wook Bang, Jin Seok Park, Hyung Kil Kim, Yong Woon Shin, Kye Sook Kwon, Joon Mee Kim
    Gastroenterology Research and Practice.2016; 2016: 1.CrossRef
  • Surgical treatment and prognosis of gastric neuroendocrine neoplasms: a single-center experience
    Chaoyong Shen, Huijiao Chen, Haining Chen, Yuan Yin, Luyin Han, Jiaju Chen, Sumin Tang, Xiaonan Yin, Zongguang Zhou, Bo Zhang, Zhixin Chen
    BMC Gastroenterology.2016;[Epub]CrossRef
  • The clinicopathological significance of angiogenesis in hindgut neuroendocrine tumors obtained via an endoscopic procedure
    Yoichiro Okubo, Osamu Motohashi, Norisuke Nakayama, Ken Nishimura, Rika Kasajima, Yohei Miyagi, Manabu Shiozawa, Emi Yoshioka, Masaki Suzuki, Kota Washimi, Kae Kawachi, Madoka Nito, Yoichi Kameda, Tomoyuki Yokose
    Diagnostic Pathology.2016;[Epub]CrossRef
  • A Case of Endoscopically Complete Remission of Esophageal Neuroendocrine Tumors by Concurrent Chemoradiation Therapy
    Myung Hee Kim, Hyun Yong Jeong, Jae Kyu Seong, Hee Seok Moon, Sun Hyung Kang, Duk Ki Kim
    The Korean Journal of Gastroenterology.2016; 68(5): 265.CrossRef
  • Outcomes after local excision for rectal neuroendocrine tumor
    Yoomin Kwon, Seung-Bum Ryoo, Inho Song, Yoon-Hye Kwon, Dong Woon Lee, Sang Hui Moon, Ji Won Park, Seung-Yong Jeong, Kyu Joo Park
    Korean Journal of Clinical Oncology.2016; 12(2): 104.CrossRef
  • Multivariate analysis of metastasis-related risk factors for patients with gastroenteropancreatic neuroendocrine tumors based on clinicopathological and endoscopic features
    Caiyun Tang, Lingqi Gong, Wenli Zou, Jie Zhang, Yuqian Zhou, Xiaoping Wu, Fanggen Lu, Chunhui Ouyang, Xiaowei Liu
    Oncology Reports.2016; 36(6): 3343.CrossRef
  • Management of gastric and duodenal neuroendocrine tumors
    Yuichi Sato, Satoru Hashimoto, Ken-ichi Mizuno, Manabu Takeuchi, Shuji Terai
    World Journal of Gastroenterology.2016; 22(30): 6817.CrossRef
  • Surgical management for non-functional pancreatic neuroendocrine neoplasms with synchronous liver metastasis: A consensus from the Chinese Study Group for Neuroendocrine Tumors (CSNET)
    Kaizhou Jin, Jin Xu, Jie Chen, Minhu Chen, Rufu Chen, Ye Chen, Zhiyu Chen, Bin Cheng, Yihebali Chi, Shi-Ting Feng, Deliang Fu, Baohua Hou, Dan Huang, Heguang Huang, Qiang Huang, Jie Li, Ying Li, Houjie Liang, Rong Lin, An'an Liu, Jixi Liu, Xubao Liu, Ming
    International Journal of Oncology.2016; 49(5): 1991.CrossRef
  • ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors
    M. Falconi, B. Eriksson, G. Kaltsas, D.K. Bartsch, J. Capdevila, M. Caplin, B. Kos-Kudla, D. Kwekkeboom, G. Rindi, G. Klöppel, N. Reed, R. Kianmanesh, R.T. Jensen
    Neuroendocrinology.2016; 103(2): 153.CrossRef
  • Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis
    Tetsuhide Ito, Hisato Igarashi, Kazuhiko Nakamura, Hironobu Sasano, Takuji Okusaka, Koji Takano, Izumi Komoto, Masao Tanaka, Masayuki Imamura, Robert T. Jensen, Ryoichi Takayanagi, Akira Shimatsu
    Journal of Gastroenterology.2015; 50(1): 58.CrossRef
  • Neuroendocrine neoplasms of the extrahepatic bile duct: radiologic and clinical characteristics
    Nurhee Hong, Hyoung Jung Kim, Jae Ho Byun, So Yeon Kim, Kyoung Won Kim, Jin Hee Kim, Seung-Mo Hong
    Abdominal Imaging.2015; 40(1): 181.CrossRef
  • Circumferential submucosal incision prior to endoscopic mucosal resection provides comparable clinical outcomes to submucosal dissection for well-differentiated neuroendocrine tumors of the rectum
    Dae Young Cheung, Soo Kyoung Choi, Hyung-Keun Kim, Sung Soo Kim, Hiun-Suk Chae, Kyung Jin Seo, Young-Seok Cho
    Surgical Endoscopy.2015; 29(6): 1500.CrossRef
  • Non-L-cell Immunophenotype and Large Tumor Size in Rectal Neuroendocrine Tumors Are Associated With Aggressive Clinical Behavior and Worse Prognosis
    Joo Young Kim, Ki-Suk Kim, Kyung-Jo Kim, In Ja Park, Jong Lyul Lee, Seung-Jae Myung, Yangsoon Park, Young Soo Park, Chang Sik Yu, Jin Cheon Kim, Eunsil Yu, Hyeung-Jin Jang, Seung-Mo Hong
    American Journal of Surgical Pathology.2015; 39(5): 632.CrossRef
  • Aggressive Locoregional Treatment Improves the Outcome of Liver Metastases from Grade 3 Gastroenteropancreatic Neuroendocrine Tumors
    Shunda Du, Jianjiao Ni, Linqian Weng, Fei Ma, Shaohua Li, Wenze Wang, Xinting Sang, Xin Lu, Shouxian Zhong, Yilei Mao
    Medicine.2015; 94(34): e1429.CrossRef
  • Gastroenteropancreatic Neuroendocrine Tumors with Liver Metastases in Korea: A Clinicopathological Analysis of 72 Cases in a Single Institute
    Yooju Shin, Sang Yun Ha, Jiyeon Hyeon, Boram Lee, Jeeyun Lee, Kee-Taek Jang, Kyoung-Mee Kim, Young Suk Park, Cheol-Keun Park
    Cancer Research and Treatment.2015; 47(4): 738.CrossRef
  • Prognostic Significance of Defining L-Cell Type on the Biologic Behavior of Rectal Neuroendocrine Tumors in Relation with Pathological Parameters
    Jin Hee Sohn, Mee-Yon Cho, Yangsoon Park, Hyunki Kim, Woo Ho Kim, Joon Mee Kim, Eun Sun Jung, Kyoung-Mee Kim, Jae Hyuk Lee, Hee Kyung Chan, Do Youn Park, Mee Joo, Sujin Kim, Woo Sung Moon, Mi Seon Kang, So-Young Jin, Yun Kyung Kang, Sun Och Yoon, HyeSeung
    Cancer Research and Treatment.2015; 47(4): 813.CrossRef
  • Neuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive Review
    Emma Ilett, Seppo Langer, Ingrid Olsen, Birgitte Federspiel, Andreas Kjær, Ulrich Knigge
    Diagnostics.2015; 5(2): 119.CrossRef
  • A Re-evaluation of Colorectal Neuroendocrine Tumors Based on WHO 2010
    Akira Watanabe, Mitsuyoshi Ota, Yusuke Suwa, Shinsuke Suzuki, Atsushi Ishibe, Jun Watanabe, Kazuteru Watanabe, Yasushi Ichikawa, Kingo Hirasawa, Mikiko Tanabe, Itaru Endo
    Nippon Daicho Komonbyo Gakkai Zasshi.2015; 68(2): 61.CrossRef
  • Gastroenteropancreatic high‐grade neuroendocrine carcinoma
    Halfdan Sorbye, Jonathan Strosberg, Eric Baudin, David S. Klimstra, James C. Yao
    Cancer.2014; 120(18): 2814.CrossRef
  • Mixed Large Cell Neuroendocrine Carcinoma and Adenocarcinoma with Spindle Cell and Clear Cell Features in the Extrahepatic Bile Duct
    John Wysocki, Rishi Agarwal, Laura Bratton, Jeremy Nguyen, Mandy Crause Weidenhaft, Nathan Shores, Hillary Z. Kimbrell
    Case Reports in Pathology.2014; 2014: 1.CrossRef
  • Spectrum of Gastroenteropancreatic NENs in Routine Histological Examinations of Bioptic and Surgical Specimen: A Study of 161 Cases Collected from 17 Departments of Pathology in the Czech Republic
    Václav Mandys, Tomáš Jirásek
    Gastroenterology Research and Practice.2014; 2014: 1.CrossRef
  • Italian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms
    Franco Grimaldi, Nicola Fazio, Roberto Attanasio, Andrea Frasoldati, Enrico Papini, Francesco Angelini, Roberto Baldelli, Debora Berretti, Sara Bianchetti, Giancarlo Bizzarri, Marco Caputo, Roberto Castello, Nadia Cremonini, Anna Crescenzi, Maria Vittoria
    Journal of Endocrinological Investigation.2014; 37(9): 875.CrossRef
  • Clinical features and management of type I gastric carcinoids
    Yuichi Sato
    Clinical Journal of Gastroenterology.2014; 7(5): 381.CrossRef
  • Diagnosis and Treatment of Rectal Neuroendocrine Tumor
    Hyun Deok Shin
    Korean Journal of Medicine.2014; 87(4): 415.CrossRef
  • Clinical, pathological and prognostic characteristics of gastroenteropancreatic neuroendocrine neoplasms in China: a retrospective study
    Xianbin Zhang, Li Ma, Haidong Bao, Jing Zhang, Zhongyu Wang, Peng Gong
    BMC Endocrine Disorders.2014;[Epub]CrossRef
  • The clinical features and treatment modality of esophageal neuroendocrine tumors: a multicenter study in Korea
    Chang Geun Lee, Yun Jeong Lim, Seun Ja Park, Byung Ik Jang, Seok Reyol Choi, Jae Kwang Kim, Yong-Tae Kim, Joo Young Cho, Chang Hun Yang, Hoon Jai Chun, Si Young Song
    BMC Cancer.2014;[Epub]CrossRef
  • A Modified Duodenal Neuroendocrine Tumor Staging Schema Better Defines the Risk of Lymph Node Metastasis and Disease-free Survival
    Swapnil D. Kachare, Kendall R. Liner, Nasreen A. Vohra, Emmanuel E. Zervos, Timothy L. Fitzgerald
    The American Surgeon™.2014; 80(8): 821.CrossRef
  • A Case of Small Cell Neuroendocrine Tumor Occurring at Hilar Bile Duct
    Bum Chul Kim, Tae Jun Song, Hyuk Lee, Mee Joo, Won Ki Bae, Nam-Hoon Kim, Kyung-Ah Kim, June Sung Lee
    The Korean Journal of Gastroenterology.2013; 62(5): 301.CrossRef
  • Neuroendocrine Tumors
    Young Suk Park
    Korean Journal of Medicine.2013; 85(4): 354.CrossRef
  • Role of radiotherapy for pancreatobiliary neuroendocrine tumors
    Jeongshim Lee, Jinhyun Choi, Chihwan Choi, Jinsil Seong
    Radiation Oncology Journal.2013; 31(3): 125.CrossRef
  • Proposal for a Standardized Pathology Report of Gastroenteropancreatic Neuroendocrine Tumors: Prognostic Significance of Pathological Parameters
    Mee-Yon Cho, Jin Hee Sohn, So Young Jin, Hyunki Kim, Eun Sun Jung, Mi-Jung Kim, Kyoung-Mee Kim, Woo Ho Kim, Joon Mee Kim, Yun Kyung Kang, Joon Hyuk Choi, Dae Young Kang, Youn Wha Kim, Eun Hee Choi
    Korean Journal of Pathology.2013; 47(3): 227.CrossRef
  • Multiple Neuroendocrine Tumor of the Distal Ileum
    Seung Min Lee, Jong Hoon Lee
    The Korean Journal of Gastroenterology.2013; 61(2): 110.CrossRef
  • The Epidemiology of Neuroendocrine Tumors in Taiwan: A Nation-Wide Cancer Registry-Based Study
    Hui-Jen Tsai, Chun-Chieh Wu, Chia-Rung Tsai, Sheng-Fung Lin, Li-Tzong Chen, Jeffrey S. Chang, Olga Y. Gorlova
    PLoS ONE.2013; 8(4): e62487.CrossRef
  • Which endoscopic treatment is the best for small rectal carcinoid tumors?
    Hyun Ho Choi
    World Journal of Gastrointestinal Endoscopy.2013; 5(10): 487.CrossRef
  • Prognostic impact of p16 and p21 on gastroenteropancreatic neuroendocrine tumors
    SHUZHENG LIU, YUXI CHANG, JIE MA, XU LI, XIAOHONG LI, JINHU FAN, RONG HUANG, GUANGCAI DUAN, XIBIN SUN
    Oncology Letters.2013; 6(6): 1641.CrossRef
  • Epidemiology of gastroenteropancreatic neuroendocrine tumours
    M. Fraenkel, M.K. Kim, A. Faggiano, G.D. Valk
    Best Practice & Research Clinical Gastroenterology.2012; 26(6): 691.CrossRef
  • 25,148View
  • 285Download
  • 157Crossref
Gene Promoter Hypermethylation in Tumors and Plasma of Breast Cancer Patients
Young Kyung Bae, Young Ran Shim, Joon Hyuk Choi, Mi Jin Kim, Edward Gabrielson, Soo Jung Lee, Tae Yoon Hwang, Sei One Shin
Cancer Res Treat. 2005;37(4):233-240. Published online August 31, 2005
DOI: https://doi.org/10.4143/crt.2005.37.4.233
AbstractCancer Research and Treatment (7)PDFPubReaderePub
Purpose

To measure the hypermethylation of four genes in primary tumors and paired plasma samples to determine the feasibility of gene promoter hypermethylation markers for detecting breast cancer in the plasma.

Materials and Methods

DNA was extracted from the tumor tissues and peripheral blood plasma of 34 patients with invasive breast cancer, and the samples examined for aberrant hypermethylation in cyclin D2, retinoic acid receptor β (RARβ), twist and high in normal-1 (HIN-1) genes using methylation-specific PCR (MSP), and the results correlated with the clinicopathological parameters.

Results

Promoter hypermethylation was detected at high frequency in the primary tumors for cyclin D2 (53%), RARβ (56%), twist (41%) and HIN-1 (77%). Thirty-three of the 34 (97%) primary tumors displayed promoter hypermethylation in at least one of the genes examined. The corresponding plasma samples showed hyperme thylation of the same genes, although at lower frequencies (6% for cyclin D2, 16% for RARβ, 36% for twist, and 54% for HIN-1). Overall, 22 of the 33 (67%) primary tumors with hypermethylation of at least one of the four genes also had abnormally hypermethylated DNA in their matched plasma samples. No significant relationship was recognized between any of the clinical or pathological parameters (tumor size, axillary lymph node metastasis, stage, or Ki-67 labeling index) with the frequency of hypermethylated DNA in the primary tumor or plasma.

Conclusion

The detection of aberrant promoter hypermethylation of cancer-related genes in the plasma may be a useful tool for the detection of breast cancer.

Citations

Citations to this article as recorded byCancer Research and Treatment (10)

  • GPI: An indicator for immune infiltrates and prognosis of human breast cancer from a comprehensive analysis
    Jie Zeng, Jianing Yi, Siyi Tan, Yuanjun Zeng, Lianhong Zou, Chaojie Zhang, Luyao Liu, Pingyong Yi, Peizhi Fan, Jie Yu
    Frontiers in Endocrinology.2022;[Epub]CrossRef
  • Aberrantly Methylated cfDNA in Body Fluids as a Promising Diagnostic Tool for Early Detection of Breast Cancer
    Igor Stastny, Pavol Zubor, Karol Kajo, Peter Kubatka, Olga Golubnitschaja, Zuzana Dankova
    Clinical Breast Cancer.2020; 20(6): e711.CrossRef
  • Epigenetic Modifications as Biomarkers of Tumor Development, Therapy Response, and Recurrence across the Cancer Care Continuum
    Margaret Thomas, Paola Marcato
    Cancers.2018; 10(4): 101.CrossRef
  • Promoter Hypermethylation Analysis of the Tumor Suppressor Genes RASSF1A and RASSF2A in Iranian Endometrial Carcinoma Patients
    Neda Jabbara, Golnaz Asaadi Tehrani, Fatemeh Lalooha, Seyed Amir Farzam, Khadijeh Elmizadeh
    International Journal of Cancer Management.2017;[Epub]CrossRef
  • Recent Progress in Triple Negative Breast Cancer Research
    Fatima Zahra Mouh, Mohammed El Mzibri, Meriem Slaoui, Mariam Amrani
    Asian Pacific Journal of Cancer Prevention.2016; 17(4): 1595.CrossRef
  • Aberrant methylation of APC and RARβ2 genes in breast cancer patients
    Menha Swellam, Mohamed D.E. Abdelmaksoud, Magda Sayed Mahmoud, Amal Ramadan, Walid Abdel‐Moneem, Mona M. Hefny
    IUBMB Life.2015; 67(1): 61.CrossRef
  • Increased Hypermethylation of Glutathione S-Transferase P1, DNA-Binding Protein Inhibitor, Death Associated Protein Kinase and Paired Box Protein-5 Genes in Triple-Negative Breast Cancer Saudi Females
    Mohamed M. Hafez, Othman A. Al-Shabanah, Salim S. Al-Rejaie, Naif O. Al-Harbi, Zeinab K. Hassan, Abdulmalik Alsheikh, Abdurrahman I. Al Theyab, Meshan L. Aldelemy, Mohamed M. Sayed-Ahmed
    Asian Pacific Journal of Cancer Prevention.2015; 16(2): 541.CrossRef
  • Modern methods in breast cancer diagnostics
    S. N. Tamkovich, V. E. Voytsitskiy, P. P. Laktionov
    Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry.2014; 8(4): 302.CrossRef
  • Promoter hypermethylation contributes to the frequent suppression of the CDK10 gene in human nasopharyngeal carcinomas
    Yanjie You, Wenjun Yang, Zhizhong Wang, Huimin Zhu, Haijun Li, Canfeng Lin, Yonggang Ran
    Cellular Oncology.2013; 36(4): 323.CrossRef
  • Hide and seek: tell-tale signs of breast cancer lurking in the blood
    David S. Guttery, Kevin Blighe, Karen Page, Stephanie D. Marchese, Allison Hills, R. Charles Coombes, Justin Stebbing, Jacqueline A. Shaw
    Cancer and Metastasis Reviews.2013; 32(1-2): 289.CrossRef
  • RAD51C-Deficient Cancer Cells Are Highly Sensitive to the PARP Inhibitor Olaparib
    Ahrum Min, Seock-Ah Im, Young-Kwang Yoon, Sang-Hyun Song, Hyun-Jin Nam, Hyung-Seok Hur, Hwang-Phill Kim, Kyung-Hun Lee, Sae-Won Han, Do-Youn Oh, Tae-You Kim, Mark J. O'Connor, Woo-Ho Kim, Yung-Jue Bang
    Molecular Cancer Therapeutics.2013; 12(6): 865.CrossRef
  • Improving early breast cancer detection: focus on methylation
    K.P.M. Suijkerbuijk, P.J. van Diest, E. van der Wall
    Annals of Oncology.2011; 22(1): 24.CrossRef
  • 9,924View
  • 56Download
  • 12Crossref
Correlation between p53 and Rb Protein Expression and Clinicopathologic Features in Hepatocellular Carcinoma
Mi Jin Gu, Joon Hyuk Choi
Cancer Res Treat. 2003;35(6):514-520. Published online December 31, 2003
DOI: https://doi.org/10.4143/crt.2003.35.6.514
AbstractCancer Research and Treatment (12)PDF
PURPOSE
Hepatocellular carcinomas (HCC) are one of the most common cancers in Korea. The mechanism of HCC development is still unclear, and the aberration of the tumor suppressor genes in HCC remains to be clarified. MATERIALS AND METHODS: To study the expressions of p53 and Rb protein, and their correlation with the clinicopathological parameters in HCC, 68 patients, with surgically resected hepatocellular carcinomas, were analyzed by an immunohistochemical method.The expressions of p53 and Rb protein were classified into three categorizes, depending on the percentage of stained cells. RESULTS: The expression of the p53 protein was 51.5% (35/68), and was significantly correlated with differentiation (p<0.05). The altered Rb protein expression was 72.2% (49/68). The expressions of p53 and altered Rb protein had no significant correlation with the tumor size, gender, WHO histological pattern, cirrhosis or vascular invasion (p>0.05). There was a positive correlation between p53 and Rb protein overexpression (p<0.05). The expressions of p53 and Rb protein had correlation with the Ki-67 labeling index (p<0.05). CONCLUSION: These findings suggest the aberrant expressions of p53 and Rb protein may play a role in the progression and carcinogenesis of HCC.

Citations

Citations to this article as recorded byCancer Research and Treatment (13)

  • Clinical significance of down-regulated HINT2 in hepatocellular carcinoma
    Dong-Kai Zhou, Xiao-Hui Qian, Jun Cheng, Ling-Hui Chen, Wei-Lin Wang
    Medicine.2019; 98(48): e17815.CrossRef
  • 3,872View
  • 19Download
  • 1Crossref
Cancer Research and Treatment (2024)
Top Articles
Latest Posts
Recommended Articles
Article information

Author: Horacio Brakus JD

Last Updated:

Views: 5527

Rating: 4 / 5 (71 voted)

Reviews: 86% of readers found this page helpful

Author information

Name: Horacio Brakus JD

Birthday: 1999-08-21

Address: Apt. 524 43384 Minnie Prairie, South Edda, MA 62804

Phone: +5931039998219

Job: Sales Strategist

Hobby: Sculling, Kitesurfing, Orienteering, Painting, Computer programming, Creative writing, Scuba diving

Introduction: My name is Horacio Brakus JD, I am a lively, splendid, jolly, vivacious, vast, cheerful, agreeable person who loves writing and wants to share my knowledge and understanding with you.